Royalty Pharma (RPRX) holder TPC RP EPA1 LLC eyes 11,002-share stock sale
Rhea-AI Filing Summary
TPC RP EPA1 LLC, an affiliate stockholder of Royalty Pharma plc (symbol RPRX), filed a notice of proposed sale of 11,002 shares of common stock through Goldman Sachs & Co. LLC. The shares were acquired on 08/05/2026 as compensation under performance awards from the issuer.
The filing also lists a prior transaction in the last three months, where TPC RP EPA1 LLC sold 64,399 shares of common stock on 05/26/2026 for an aggregate amount of $3,476,118.96.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed for sale: 11,002 shares of common stock
Shares sold in past 3 months: 64,399 shares of common stock
Aggregate amount from prior sale: $3,476,118.96
+2 more
5 metrics
Shares proposed for sale
11,002 shares of common stock
Securities to be sold as listed in the Form 144 notice
Shares sold in past 3 months
64,399 shares of common stock
Securities sold on 05/26/2026 during the past 3 months
Aggregate amount from prior sale
$3,476,118.96
Aggregate amount for 64,399 shares sold on 05/26/2026
Acquisition date of compensation shares
08/05/2026
Date 11,002 shares were acquired as compensation via performance awards
Planned sale reference date
08/13/2026
Date associated with common stock entry and NASD trading line
Key Terms
Securities To Be Sold, Securities Sold During The Past 3 Months, Performance Awards
3 terms
Securities To Be Sold regulatory
"144: Securities To Be Sold Common Stock | 08/05/2026 | Acquired as compensation"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months TPC RP EPA1 LLC 110 East 59th Street"
Performance Awards financial
"Acquired as compensation -- Performance Awards | The Issuer | | | 11002"
FAQ
What stock sale is TPC RP EPA1 LLC planning for RPRX under this Form 144?
TPC RP EPA1 LLC filed to potentially sell 11,002 shares of Royalty Pharma (RPRX) common stock. The notice lists Goldman Sachs & Co. LLC as broker and identifies the shares as acquired as compensation via performance awards on 08/05/2026.
What is the aggregate dollar value disclosed for recent RPRX stock sales?
For the sale on 05/26/2026, TPC RP EPA1 LLC reports an aggregate amount of $3,476,118.96. This corresponds to the disposition of 64,399 RPRX common shares during the past three months.
AI-generated analysis. How Rhea-AI works. Not financial advice.